https://www.indianpharmapost.com/zydus-cadila-entity-to-sell-its-india-focused-animal-health-business-to-a-consortium-86102021-05-13T00:00:00+05:30always0.9https://www.indianpharmapost.com/eris-lifesciences-reports-q4fy21-consolidated-net-profit-of-rs-6824-cr-86172021-05-13T00:00:00+05:30always0.9https://www.indianpharmapost.com/covaxin-phase-iiiii-clinical-trial-approved-for-2-18-years-86192021-05-13T00:00:00+05:30always0.9https://www.indianpharmapost.com/torrent-pharma-enters-into-agreement-with-lilly-for-baricitinib-for-covid-19-in-india-86282021-05-13T00:00:00+05:30always0.9https://www.indianpharmapost.com/lupin-reports-q4fy21-consolidated-pat-of-rs-46036-cr-86312021-05-13T00:00:00+05:30always0.9